在接受 omalizumab 治疗的严重喘患者中,随着时间的推移,临床缓解得到维持和改善
Aykut Cilli1, Fatih Uzer1, Gamze Ozbey1
1Department of Respiratory Disease, Akdeniz University, Antalya, Türkiye.
概括
奥马利祖马布治疗可以导致严重喘患者的临床缓解,缓解率在五年内增加. 虽然一些因素在缓解者中更高,但在这个真实世界的研究中,没有一个因素预测了缓解.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
背景情况:
- 严重喘治疗正在发展,临床缓解成为治疗目标.
- 奥马利祖马布是治疗严重过敏性喘的既定疗法.
- 现实世界的数据对于了解不同患者群体的治疗结果至关重要.
研究的目的:
- 评估用奥马利祖马布治疗的严重喘患者的临床缓解率.
- 为了确定实现临床缓解的潜在预测因素.
- 评估缓解的长期维持和改善随着时间的推移.
主要方法:
- 在58名重症喘患者的回顾性观察性研究中,他们开始服用奥马利祖马布.
- 临床缓解定义为没有使用口服皮质类固醇,没有恶化,喘控制问卷 (ACQ) 评分≤1或喘控制测试 (ACT) 评分≥20,预测FEV1≥80%.
- 来自土耳其阿克德尼兹大学医院收集的数据.
主要成果:
- 临床缓解率从1年至2年期间的25.9%增加到5年期间的47.4%.
- 在1年内实现缓解的患者具有更高的前omalizumab ACT评分,FEV1 (%) 和较低的口服皮质类固醇 (OCS) 使用.
- 后勤回归分析没有发现临床缓解的任何显著预测因素.
结论:
- 奥马利祖马布在大量严重喘患者中显示出诱导和维持临床缓解的潜力.
- 缓解率有所改善,并在长时间的治疗期间保持.
- 可能需要进一步的研究来确定奥马利祖马布诱导缓解的精确预测因子.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
273
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
273
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
236
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
236
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
01:19Antiasthma Drugs: Leukotriene Modifiers
276
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
276
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:17Drugs Used in Lower Respiratory Disorders: Overview
421
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
421